...

PDFファイル

by user

on
Category: Documents
8

views

Report

Comments

Transcript

PDFファイル
**2015
11
*2014
)
)
10
(07)
)
21900BZY00011000
70488000
AAA- 2 0 1 5 0 2 - 1 1
®
9)
1)
10)
11)
2)
1)
2)
19-32mm
15mm
60°
1)
8-25mm
®
10cm
®
2)
3)
]
3)
4)
(DSA)
5)
6)
4)
7)
5)
6)
7)
8)
21
1/8
•
]
AAA
(
•
*• 16 18 20mm:
*• 23mm:
*• 27mm:
10cm
1)
(PTFE)
FEP
3cm
4cm
5cm
6cm
(
10cm
)
PTFE/FEP
PTFE/FEP
PTFE/FEP
*(
)
®
X
X
3
1
X
3cm
X
1
3.3cm
4.5cm
X
X
7cm
X
X
1
1
X
X
3
X
**
X
/PTFE/FEP
X
PTFE
X
X
12 14.5mm
3
]
23 26 28.5mm *
31 35mm† )
PTFE/FEP
*†
•
•
•
•
X
1)
*2)
X
19-32mm
15mm
3)
*4)
60°
8-25mm
10mm
12 14.5mm
**
•
X
X
16 18 20 23 27mm
145cm
**
**
2/8
0.035
(0.89mm)
(super-stiff)
**
*
3.
)
14mm
*
(mm)
(mm) †1
19-21
23
22-23
26
24-26
28.5
27-29
32
*30-32
*36
†
1
*†2
(Fr) †2
(cm)
16†3, 18
3.3
16†3, 18
(28.5mm
18Fr)
*17†3
4.5
18Fr), 20
*18
10-21%
40cm
]
*†3
2mm
(10-21%
1mm
PLA
**
4.
)
7-25%
(mm)
**
1.
8-9
10
10-11
12-13.5
12†5
14.5†5
)
†
(mm)
(mm) †1
19-21
(mm)
23
22-23
26
24-26
28.5
(mm) †1
10-11
12-13.5
12
14.5
10-11
12
12-13.5
14.5
10-11
12-13.5
12
14.5
†2
(Fr)†3
(cm)
†
†
31
12-13.5
14.5
13, 15, 17
18†4, 20
*35†4
*12-13.5
*14.5
*14, 16, 18
*18
1
2
*†3
10-21%
12mm
7
12
(mm)
(mm)†4
14
12
14
10
7-25%
4cm
40cm
40mm
12 14.5mm
1.
7-25%
14mm
**2.
40cm
**†4
(Fr)†3
18
27-29
†
(cm) †2
3cm
*4
**†5
16 , 18
12, 14, 16, 18
*30-32
†
1
2
3
†
†4
(mm) †1
RLT
3mm
3.
DSA
CT
**
2.
(mm)
10 - 11
) †1
(mm)†2
12
(cm) †3
†4
10, 12, 14
12 -13.5
14.5
13.5 -14.5
14.5 -16.5
16
18
16.5 -18.5
20
18.5 -21.5
*23
4.
5.
(mm)
(Fr)†5
(mm)†6
12
1.
14
12
14
9.5, 11.5, 13.5
*10, 12, 14
16
18
†8
*12 , 18
*2.
20
3.
14†7
*14
15mm
19-32mm
*24
60°
*15
21.5 -25
*27
4.
*28
*10, 12, 14
16Fr)
**†1
†
2
*†3
7-25%
23 26 28.5mm
35mm
†
4
*†5
5cm(
4cm(
31mm
6cm(
2mm
3cm
40cm
*5.
†
6
40mm
* 7 16 18 20 23 27mm
†
*†8
25%
30mm
10mm
25mm
16mm
10mm
PLC
6.
7.
8.
3/8
9.
1.
DSA
10.
2.
11.
3.
0.035
mm
0.89
super-stiff
4.
5.
12.
6.
*13.
7.
14.
1.
2.
1.
3.
2.
0.035
super-stiff
4.
**3.
5.
12 14.5mm
4.
1.
5.
2.
0.035
mm
0.89
super-stiff
**6.
*3.
12 14.5mm
**7.
3cm
4.
*8.
**9.
**10.
5.
**11.
6.
60-70
**12.
mmHg
7.
**13.
**8.
4/8
14mm
0.89 mm
**14.
3cm
4cm 16 18 20mm
6cm 27mm
10cm
**15.
5cm 23mm
1.
2.
0.035
0.89mm
7B
super-stiff
18 20 23 27mm
3cm
*3.
*4.
4.
**5.
**6.
3.3cm
4.5cm
1.6cm
2.2cm
**7.
**8.
5.
60
70 mmHg
**9.
**6.
7.
8.
9.
10.
*
16, 18, 20, 23, 27mm
**
**
1.
3cm
2.
**
3cm
18, 20, 23, 27mm
3.
3cm
**1
**1.
12 14.5mm
3cm
3.3cm
3cm
*2
1.6cm 4.5cm
2.2cm
3.3cm
1.6cm 4.5cm
3cm
16 18 20 23 27mm
2.2cm
3cm
7cm
4cm
7A 7B 7C
3cm
3cm
3cm
2.
5/8
3.
CT
Smart-Prep†, Care
Delay
1cm
**
DFOV
CT
**
32cm
MRI/MRA
(mm/rot)
CT
interval)(mm)
KV/mA
†
MRI/MRA
CT
CT
CT
Smart-Prep
32cm
0.8
0.8
3.0mm
3.0mm
HS
HS
15
15
2.0
2.0
120/300
120/300
3.0mm Soft
3.0mm Soft
ROI Loc: 1cm Sup.
delay 6sec.
ISD 3sec. MA 40
3sec.
Enhance thres: 100HU
Supine AP
Lateral
30°LPO
30°
30°RPO
30°
CT
CT
CO2
MRI/MRA
5.
2-4
CT†1
†2
MRI
MR
†3
***-
12
†
** 1 CT
†
2
†
3 1
3.0
3000
/cm
Specific absorption rate SAR
2.0W/kg
15
MRI
**
10-20cm
1.5
/64MHz (Magnetom, Siemens Medical
Solutions,Malvern, PA. Software Numeris/4, Version Syngo MR 2002B
DHHS Active-shielded,horizontal field scanner
/128MHz
(Excite, HDx, Software 14X.M5, General Electric Healthcare, Milwaukee,
WI) MR
15
MRI
1cm
Supine
7. MRI
AP
AP
SAR
SAR2.0W/kg
SAR4.0W/kg
**CT
3mm
3mm
MR
14’’× 17’’
20:1
**
CT
**
CT
**
**
CT
CT
10mm
MR
MRI
MRI
6.
mL
mL/sec
Type
Type
150
5mm
2.5
6/8
1.5
2.9W/kg
2.9W/kg
2.1W/kg
2.7W/kg
2.2
2.7
1.5
1.9
3.0
3.7
**
16Fr 17Fr 18Fr
12Fr
14Fr
20Fr
15mm
32mm
60°
30mm
10mm
360°
**
16, 18, 20, 23, 27mm
3cm
18, 20, 23, 27mm
27mm
10cm
3cm
31 35mm
32, 36mm
15mm
22mm
15mm
7/8
25mm
9.
1
6
12
24
36
48
99
96
87
81
70
58
46
99
‡
68
(68.7%)
45
(45.5%)
12
(12.1%)
16
(16.2%)
3
(3.0%)
4
(4.0%)
17
(17.2%)
7
(7.1%)
3
(3.0%)
1
(1.0%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
1
(1.0%)
15
(15.6%)
0
(0.0%)
3
(3.1%)
7
(7.3%)
0
(0.0%)
3
(3.1%)
2
(2.1%)
1
(1.0%)
3
(3.1%)
0
(0.0%)
0
(0.0%)
1
(1.0%)
0
(0.0%)
2
(2.1%)
10
(11.5%)
0
(0.0%)
1
(1.1%)
7
(8.0%)
1
(1.1%)
0
(0.0%)
1
(1.1%)
3
(3.4%)
2
(2.3%)
2
(2.3%)
0
(0.0%)
2
(2.3%)
0
(0.0%)
2
(2.3%)
11
(13.6%)
0
(0.0%)
2
(2.5%)
6
(7.4%)
0
(0.0%)
1
(1.2%)
1
(1.2%)
1
(1.2%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
2
(2.5%)
12
(17.1%)
0
(0.0%)
1
(1.4%)
6
(8.6%)
1
(1.4%)
2
(2.9%)
2
(2.9%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
3
(4.3%)
0
(0.0%)
2
(2.9%)
13
(22.4%)
1
(1.7%)
4
(6.9%)
6
(10.3%)
3
(5.2%)
1
(1.7%)
1
(1.7%)
0
(0.0%)
2
(3.4%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
1
(1.7%)
3
(6.5%)
0
(0.0%)
0
(0.0%)
1
(2.2%)
0
(0.0%)
0
(0.0%)
1
(2.2%)
1
(2.2%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
0
(0.0%)
80
(80.8%)
45
(45.5%)
19
(19.2%)
36
(36.4%)
7
(7.1%)
10
(10.1%)
22
(22.2%)
12
(12.1%)
9
(9.1%)
3
(3.0%)
0
(0.0%)
6
(6.1%)
0
(0.0%)
9
(9.1%)
547-911
0-60
912-1275
36
48
61-242
12
1276-1640
98-03
®
19
235
99
EBE
32mm
03-02
EBE
98-03
Continued Access
60
†
243-546
24
60
1641-2006
98-03
31mm
03-02
2008
35
49
99-04
16
193
Continued Access
EBE
88
EBE
EBE(98-03 99-04)
99
1.
(5mm
98-03
99-04
EBE99-04
8.
†
‡
EBE98-03
98-03
2.
Jon S. Matsumura et al. A multicenter controlled clinical trial of open
EBE98-03 EBE99-04
1
565
105
(18.6%)
27
(4.8%)
13
(2.3%)
22
(3.9%)
9
(1.6%)
22
(3.9%)
12
(2.1%)
16
(2.8%)
7
(1.2%)
6
(1.1%)
1
(0.2%)
3
(0.5%)
0
(0.0%)
8
(1.4%)
6
553
72
(13.0%)
2
(0.4%)
13
(2.4%)
21
(3.8%)
6
(1.1%)
9
(1.6%)
5
(0.9%)
10
(1.8%)
5
(0.9%)
5
(0.9%)
2
(0.4%)
8
(1.4%)
0
(0.0%)
12
(2.2%)
12
533
91
(17.1%)
1
(0.2%)
17
(3.2%)
24
(4.5%)
5
(0.9%)
3
(0.6%)
10
(1.9%)
9
(1.7%)
12
(2.3%)
0
(0.0%)
0
(0.0%)
16
(3.0%)
0
(0.0%)
26
(4.9%)
24
483
81
(16.8%)
3
(0.6%)
10
(2.1%)
23
(4.8%)
6
(1.2%)
4
(0.8%)
10
(2.1%)
8
(1.7%)
9
(1.9%)
1
(0.2%)
2
(0.4%)
10
(2.1%)
0
(0.0%)
19
(3.9%)
36
427
64
(15.0%)
1
(0.2%)
24
(5.6%)
23
(5.4%)
6
(1.4%)
1
(0.2%)
4
(0.9%)
5
(1.2%)
8
(1.9%)
0
(0.0%)
0
(0.0%)
11
(2.6%)
0
(0.0%)
8
(1.9%)
48
361
53
(14.7%)
5
(1.4%)
10
(2.8%)
21
(5.8%)
1
(0.3%)
1
(0.3%)
2
(0.6%)
2
(0.6%)
3
(0.8%)
3
(0.8%)
2
(0.6%)
14
(3.9%)
1
(0.3%)
11
(3.0%)
60
291
22
(7.6%)
0
(0.0%)
7
(2.4%)
10
(3.4%)
3
(1.0%)
0
(0.0%)
2
(0.7%)
2
(0.7%)
0
(0.0%)
1
(0.3%)
0
(0.0%)
1
(0.3%)
0
(0.0%)
2
(0.7%)
versus endovascular treatment of abdominal aortic aneurysm. J Vasc
565
326
(57.7%)
38
(6.7%)
81
(14.3%)
124
(21.9%)
30
(5.3%)
37
(6.5%)
43
(7.6%)
44
(7.8%)
38
(6.7%)
16
(2.8%)
7
(1.2%)
61
(10.8%)
1
(0.2%)
77
(13.6%)
Surg, 37:262-271, 2003.
TEL 03-6746-2560
W. L. Gore & Associates, Inc.
U. S. A.
®
8/8
®
W. L. Gore & Associates
Fly UP